174 related articles for article (PubMed ID: 7054319)
1. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide.
Simon GL; Klempner MS; Kasper DL; Gorbach SL
J Infect Dis; 1982 Jan; 145(1):72-7. PubMed ID: 7054319
[TBL] [Abstract][Full Text] [Related]
2. Phagocytic and serum killing of capsulate and non-capsulate Bacteroides fragilis.
Reid JH; Patrick S
J Med Microbiol; 1984 Jun; 17(3):247-57. PubMed ID: 6726784
[TBL] [Abstract][Full Text] [Related]
3. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
Lindberg AA; Weintraub A
Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
[TBL] [Abstract][Full Text] [Related]
4. Effects of Bacteroides asaccharolyticus cells and B. fragilis surface components on serum opsonisation and phagocytosis.
Jones GR; Gemmell CG
J Med Microbiol; 1986 Nov; 22(3):225-9. PubMed ID: 3534273
[TBL] [Abstract][Full Text] [Related]
5. Participation of normal human immunoglobulins M, G, and A in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by human polymorphonuclear leukocytes.
Bjornson AB; Bjornson HS; Kitko BP
Infect Immun; 1980 May; 28(2):633-7. PubMed ID: 7399680
[TBL] [Abstract][Full Text] [Related]
6. Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria.
Wade BH; Kasper DL; Mandell GL
J Antimicrob Chemother; 1983 Oct; 12 Suppl C():51-62. PubMed ID: 6643341
[TBL] [Abstract][Full Text] [Related]
7. The effect of capsular polysaccharide and lipopolysaccharide of Bacteroides fragilis on polymorph function and serum killing.
Connolly JC; McLean C; Tabaqchali S
J Med Microbiol; 1984 Jun; 17(3):259-71. PubMed ID: 6374150
[TBL] [Abstract][Full Text] [Related]
8. Animal model system for studying virulence of and host response to Bacteroides fragilis.
Onderdonk AB; Cisneros RL; Finberg R; Crabb JH; Kasper DL
Rev Infect Dis; 1990; 12 Suppl 2():S169-77. PubMed ID: 2406869
[TBL] [Abstract][Full Text] [Related]
9. Specificity of immunoglobulin M antibodies in normal human serum that participate in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by by human polymorphonuclear leukocytes.
Bjornson AB; Bjornson HS; Kitko BP
Infect Immun; 1980 Oct; 30(1):263-71. PubMed ID: 6160104
[TBL] [Abstract][Full Text] [Related]
10. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.
Kasper DL
J Infect Dis; 1976 Jan; 133(1):79-87. PubMed ID: 1451
[TBL] [Abstract][Full Text] [Related]
11. Role of humoral factors in host resistance to the Bacteroides fragilis group.
Bjornson AB
Rev Infect Dis; 1990; 12 Suppl 2():S161-8. PubMed ID: 2406868
[TBL] [Abstract][Full Text] [Related]
12. Surface antigens as virulence factors in infection with Bacteroides fragilis.
Kasper DL; Onderdonk AB; Polk BF; Bartlett JG
Rev Infect Dis; 1979; 1(2):278-90. PubMed ID: 549184
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes.
Gemmell CG; Peterson PK; Schmeling D; Mathews J; Quie PG
Eur J Clin Microbiol; 1983 Aug; 2(4):327-34. PubMed ID: 6628373
[TBL] [Abstract][Full Text] [Related]
14. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
Kasper DL; Onderdonk AB
Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
[TBL] [Abstract][Full Text] [Related]
15. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
[TBL] [Abstract][Full Text] [Related]
16. Pathogenicity of Bacteroides fragilis group in rat intra-abdominal abscesses.
Jotwani R; Gupta U; Watanabe K; Ueno K
Microbiol Immunol; 1992; 36(10):1041-9. PubMed ID: 1479960
[TBL] [Abstract][Full Text] [Related]
17. Bacterial killing in vitro by abscess-derived neutrophils.
Finlay-Jones JJ; Hart PH; Spencer LK; Nulsen MF; Kenny PA; McDonald PJ
J Med Microbiol; 1991 Feb; 34(2):73-81. PubMed ID: 1990143
[TBL] [Abstract][Full Text] [Related]
18. Cellular immunity to Bacteroides fragilis capsular polysaccharide.
Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
J Exp Med; 1982 Apr; 155(4):1188-97. PubMed ID: 6174672
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic synergy: mixed intra-abdominal infections.
MacLaren DM; Namavar F; Verweij-Van Vught AM; Vel WA; Kaan JA
Antonie Van Leeuwenhoek; 1984; 50(5-6):775-87. PubMed ID: 6397140
[TBL] [Abstract][Full Text] [Related]
20. Interactions between polymorphonuclear leucocytes, Bacteroides sp, and Escherichia coli: their role in the pathogenesis of mixed infection.
Vel WA; Namavar F; Verweij-van Vught AM; Pubben AN; MacLaren DM
J Clin Pathol; 1986 Apr; 39(4):376-82. PubMed ID: 3517072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
